Clarivate Plc announced it will integrate its CompuMark trademark data and insights into Microsoft Copilot via IPOne, enabling intellectual property professionals to access trusted trademark intelligence within AI-powered workflows. This collaboration aims to improve the quality and confidence of IP decisions by combining Clarivate's authoritative data with Microsoft's AI tools. IPOne serves as the infrastructure connecting curated IP data with natural language AI agents, developed with input from Fortune 500 companies and law firms. This integration marks a significant step in enhancing how IP professionals research and analyze trademarks using AI technology.
Clarivate's integration with Microsoft Copilot offers new IP data access. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 02, 2026 19:21 WIB: 96 of 150 stocks rose, 40 fell. Notable movers include AEHR at USD 57.15 (+4.08%), API at USD 4.23 (-3.64%), and ASX at USD 40.88 (+3.49%).
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
